BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27941157)

  • 1. Association between high-sensitivity troponin T and cardiovascular risk in individuals with and without metabolic syndrome: The ARIC study.
    Pokharel Y; Sun W; Villareal DT; Selvin E; Virani SS; Ndumele CE; Hoogeveen RC; Coresh J; Boerwinkle E; Butler KR; Solomon SD; Pankow JS; Bozkurt B; Ballantyne CM; Nambi V
    Eur J Prev Cardiol; 2017 Apr; 24(6):628-638. PubMed ID: 27941157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study.
    Jia X; Sun W; Hoogeveen RC; Nambi V; Matsushita K; Folsom AR; Heiss G; Couper DJ; Solomon SD; Boerwinkle E; Shah A; Selvin E; de Lemos JA; Ballantyne CM
    Circulation; 2019 Jun; 139(23):2642-2653. PubMed ID: 31030544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Sensitivity Cardiac Troponin I for Risk Stratification in Older Adults.
    Tang O; Matsushita K; Coresh J; Hoogeveen RC; Windham BG; Ballantyne CM; Selvin E
    J Am Geriatr Soc; 2021 Apr; 69(4):986-994. PubMed ID: 33150614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study.
    Saunders JT; Nambi V; de Lemos JA; Chambless LE; Virani SS; Boerwinkle E; Hoogeveen RC; Liu X; Astor BC; Mosley TH; Folsom AR; Heiss G; Coresh J; Ballantyne CM
    Circulation; 2011 Apr; 123(13):1367-76. PubMed ID: 21422391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association of Socioeconomic Status With Subclinical Myocardial Damage, Incident Cardiovascular Events, and Mortality in the ARIC Study.
    Fretz A; Schneider AL; McEvoy JW; Hoogeveen R; Ballantyne CM; Coresh J; Selvin E
    Am J Epidemiol; 2016 Mar; 183(5):452-61. PubMed ID: 26861239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-sensitivity cardiac troponin T levels and secondary events in outpatients with coronary heart disease from the Heart and Soul Study.
    Beatty AL; Ku IA; Christenson RH; DeFilippi CR; Schiller NB; Whooley MA
    JAMA Intern Med; 2013 May; 173(9):763-9. PubMed ID: 23568589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
    de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
    Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head-to-head comparison of high-sensitivity troponin T and sensitive-contemporary troponin I regarding heart failure risk stratification.
    de Antonio M; Lupón J; Galán A; Vila J; Zamora E; Urrutia A; Díez C; Coll R; Altimir S; Bayes-Genis A
    Clin Chim Acta; 2013 Nov; 426():18-24. PubMed ID: 23978483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy.
    Kubo T; Kitaoka H; Yamanaka S; Hirota T; Baba Y; Hayashi K; Iiyama T; Kumagai N; Tanioka K; Yamasaki N; Matsumura Y; Furuno T; Sugiura T; Doi YL
    J Am Coll Cardiol; 2013 Oct; 62(14):1252-1259. PubMed ID: 23623916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary microvascular dysfunction and diastolic load correlate with cardiac troponin T release measured by a highly sensitive assay in patients with nonischemic heart failure.
    Takashio S; Yamamuro M; Izumiya Y; Sugiyama S; Kojima S; Yamamoto E; Tsujita K; Tanaka T; Tayama S; Kaikita K; Hokimoto S; Ogawa H
    J Am Coll Cardiol; 2013 Aug; 62(7):632-40. PubMed ID: 23644085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment.
    Lupón J; de Antonio M; Galán A; Vila J; Zamora E; Urrutia A; Bayes-Genis A
    Mayo Clin Proc; 2013 Mar; 88(3):234-43. PubMed ID: 23384388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-sensitive troponin T in chronic heart failure correlates with severity of symptoms, left ventricular dysfunction and prognosis independently from N-terminal pro-b-type natriuretic peptide.
    Jungbauer CG; Riedlinger J; Buchner S; Birner C; Resch M; Lubnow M; Debl K; Buesing M; Huedig H; Riegger G; Luchner A
    Clin Chem Lab Med; 2011 Nov; 49(11):1899-906. PubMed ID: 21892905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trials.
    Masson S; Anand I; Favero C; Barlera S; Vago T; Bertocchi F; Maggioni AP; Tavazzi L; Tognoni G; Cohn JN; Latini R;
    Circulation; 2012 Jan; 125(2):280-8. PubMed ID: 22139751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial.
    Gravning J; Askevold ET; Nymo SH; Ueland T; Wikstrand J; McMurray JJ; Aukrust P; Gullestad L; Kjekshus J;
    Circ Heart Fail; 2014 Jan; 7(1):96-103. PubMed ID: 24284025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting myocardial infarction and other serious cardiac outcomes using high-sensitivity cardiac troponin T in a high-risk stable population.
    McQueen MJ; Kavsak PA; Xu L; Shestakovska O; Yusuf S
    Clin Biochem; 2013 Jan; 46(1-2):5-9. PubMed ID: 23063983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of Lifestyle Factors and Life's Simple 7 Score to Temporal Reduction in Troponin Levels Measured by a High-Sensitivity Assay (from the Atherosclerosis Risk in Communities Study).
    Fretz A; McEvoy JW; Rebholz CM; Ndumele CE; Florido R; Hoogeveen RC; Ballantyne CM; Selvin E
    Am J Cardiol; 2018 Feb; 121(4):430-436. PubMed ID: 29268937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide.
    Lyngbæk S; Winkel P; Gøtze JP; Kastrup J; Gluud C; Kolmos HJ; Kjøller E; Jensen GB; Hansen JF; Hildebrandt P; Hilden J;
    Eur J Prev Cardiol; 2014 Oct; 21(10):1275-84. PubMed ID: 23723326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of outcome by highly sensitive troponin T in outpatients with chronic systolic left ventricular heart failure.
    Egstrup M; Schou M; Tuxen CD; Kistorp CN; Hildebrandt PR; Gustafsson F; Faber J; Goetze JP; Gustafsson I
    Am J Cardiol; 2012 Aug; 110(4):552-7. PubMed ID: 22579083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic hyperglycemia and subclinical myocardial injury.
    Rubin J; Matsushita K; Ballantyne CM; Hoogeveen R; Coresh J; Selvin E
    J Am Coll Cardiol; 2012 Jan; 59(5):484-9. PubMed ID: 22281251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complementary role of copeptin and high-sensitivity troponin in predicting outcome in patients with stable chronic heart failure.
    Tentzeris I; Jarai R; Farhan S; Perkmann T; Schwarz MA; Jakl G; Wojta J; Huber K
    Eur J Heart Fail; 2011 Jul; 13(7):726-33. PubMed ID: 21616953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.